Agios Pharmaceuticals, Inc. (AGIO) Net margin 2016–2025
Agios Pharmaceuticals, Inc. (AGIO) net profit margin by fiscal year — reported net income divided by reported revenue.
-764.4%FY2025 · since FY2016: -284.0% → -764.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -764.4% | -2611.1 pp |
| FY2024 | 1846.7% | +3159.0 pp |
| FY2023 | -1312.3% | +316.9 pp |
| FY2022 | -1629.2% | — |
| FY2019 | -349.0% | +17.6 pp |
| FY2018 | -366.6% | +365.0 pp |
| FY2017 | -731.6% | -447.6 pp |
| FY2016 | -284.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice